FDA on ‘abuse‐deterrent’ opioids

Douglas C. Throckmorton, M.D., deputy center director for regulatory programs in the Food and Drug Administration's Center for Drug Evaluation and Research, shared some key facts on “abuse‐deterrent” opioids.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: From the FDA Source Type: research